Strata Critical Medical (NASDAQ:SRTA) CEO Melissa Tomkiel Sells 29,730 Shares

Strata Critical Medical (NASDAQ:SRTA) CEO Melissa Tomkiel sold 29,730 shares of the firm’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $174,515.10. Following the sale, the chief executive officer owned 1,892,774 shares of the company’s stock, valued at $11,110,583.38. This trade represents a 1.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Stock Down 2.1%

NASDAQ SRTA traded down $0.12 during trading hours on Wednesday, reaching $5.49. 1,306,162 shares of the company were exchanged, compared to its average volume of 874,584. Strata Critical Medical has a 1 year low of $3.57 and a 1 year high of $6.50. The firm has a 50 day simple moving average of $5.14. The company has a market cap of $475.05 million, a PE ratio of -68.63 and a beta of 2.20.

Strata Critical Medical (NASDAQ:SRTA) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The business had revenue of $67.38 million during the quarter. As a group, equities analysts predict that Strata Critical Medical will post -0.14 EPS for the current year.

Hedge Funds Weigh In On Strata Critical Medical

A number of large investors have recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its position in shares of Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after acquiring an additional 172,154 shares during the period. Bank of America Corp DE boosted its position in shares of Strata Critical Medical by 16.2% in the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after acquiring an additional 25,379 shares during the period. Quantinno Capital Management LP boosted its position in shares of Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after acquiring an additional 71,155 shares during the period. Principal Financial Group Inc. bought a new position in shares of Strata Critical Medical in the first quarter valued at approximately $537,000. Finally, Seelaus Asset Management LLC boosted its position in shares of Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after acquiring an additional 6,000 shares during the period. 47.36% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. Craig Hallum started coverage on shares of Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective for the company. B. Riley Financial started coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price for the company. Finally, Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $8.00.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.